Vibration
OtherWhole-body vibration, 17 Hz, 1.1ms-2
NCT Number: NCT01245491
The purpose of this study is:
1. To study the effect of whole-body vibration on partial pressure of oxygen in arterial blood (PaO2), under hypobaric hypoxic conditions. 2. To study the effects of whole-body vibration and hypobaric hypoxia on visual contrast sensitivity. 3. To se if there is an increase in cytokines and other biomarkers under different hypobaric hypoxic conditions Our main hypothesis is that whole-body vibration may cause PaO2 to drop to a lower level, at a given altitude; than would be the case if there were no vibration present.
Looking for future studies?
Notify MeAll sexes
Interventional
Not applicable
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Whole-body vibration, 17 Hz, 1.1ms-2
Time frame: 14 minutes
Assessed at six different altitudes
Time frame: 35 minutes
Assessed at six dfferent altitudes
Time frame: 14 minutes
Assessed at six different altitudes, over a period of three minutes.
Time frame: 35 minutes
Assessed over a periode of three minutes, at six different altitudes.
Institute of Aviation Medicine, Oslo, Norway
Other Gov
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT07720960
Erythropoiesis, Hypoxia
Elche, Alicante, Spain
View Trial DetailsNCT05767385
Cardiovascular Abnormalities, Cardiovascular Diseases
San Francisco, California, United States
View Trial DetailsNCT01542177
Digestive System Diseases, Digestive System Neoplasms
Toronto, Ontario, Canada
View Trial DetailsNCT05354648
Arterial Occlusive Diseases, Arteriosclerosis
View Trial Details